4//SEC Filing
Fremeau Robert Thomas Jr. 4
Accession 0001493152-21-029137
CIK 0001349929other
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 5:05 PM ET
Size
7.4 KB
Accession
0001493152-21-029137
Insider Transaction Report
Form 4
Vyant Bio, Inc.VYNT
Fremeau Robert Thomas Jr.
Chief Scientific Officer
Transactions
- Award
Stock option (right to buy)
2021-11-01+250,000→ 250,000 totalExercise: $2.55Exp: 2031-11-01→ Common Stock (250,000 underlying) - Purchase
Common Stock, $0.0001 par value
2021-10-28$2.19/sh+1,000$2,190→ 1,000 total
Footnotes (1)
- [F1]The option shall become exercisable with respect to twenty five percent (25%) of the shares underlying the option on November 1, 2022, and the remaining seventy five percent (75%) of the shares underlying the option shall vest in thirty six (36) equal monthly installments commencing December 1, 2022; provided that the participant remains a service provider to the Company through each applicable vesting date
Documents
Issuer
Vyant Bio, Inc.
CIK 0001349929
Entity typeother
Related Parties
1- filerCIK 0001894066
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 5:05 PM ET
- Size
- 7.4 KB